Atrial Tachycardia Differential Diagnoses
- Author: Adam S Budzikowski, MD, PhD; Chief Editor: Jeffrey N Rottman, MD more...
Diagnostic Considerations
The differential diagnosis of atrial tachycardia is the differential diagnosis of supraventricular (SVT) and includes the following:
- Sinus tachycardia
- Atrial tachycardia
- Atrial flutter
- Atrial fibrillation
- AV junction–dependent reentrant tachycardias (AV nodal reentrant tachycardia and AV reentrant tachycardia using an accessory pathway)
Differentiating among these diagnoses requires ECG analysis of the tachycardia for P wave activity. The ECG of an SVT typically has narrow QRS complexes (unless aberrant conduction with typical left or right bundle-branch block occurs or bystander preexcitation is seen).
Assessment of the P waves and their relationship to the QRS complex (R waves) may reveal 2 different observations, as follows:
- In short RP (P wave immediately following the QRS) SVT, the differential diagnosis includes typical AV nodal reentrant tachycardia and AV reentrant tachycardia using accessory pathways and atrial tachycardia with long I°AV block or atrial tachycardia originating from the os of the coronary sinus or junctional tachycardia. To determine the diagnosis requires additional maneuvers such as vagal stimulation (eg, carotid sinus massage, Valsalva) or adenosine.
- In long RP interval (interval wave preceding QRS) SVT, the differential diagnosis includes atypical (fast-slow) AV nodal reentrant tachycardia and permanent junctional reciprocating tachycardia (PJRT) due to a slowly conducting retrograde accessory pathway, sinus tachycardia, sinus node reentry, atrial tachycardia, atrial flutter, or atrioventricular reentrant tachycardia. Diagnosis requires assessment of the patient condition, vagal maneuvers, adenosine, and cardioversion—namely, procedures that may not only be diagnostic but also therapeutic.
For multifocal atrial tachycardia, the differential diagnosis includes atrial fibrillation because both can manifest with an irregular pulse. Multifocal atrial tachycardia with aberration or preexisting bundle branch block may be misinterpreted as ventricular tachycardia.
The full clinical presentation must be always considered. New-onset atrial tachycardias by themselves are relatively benign. However, if the patient also has new problems (eg, chest pain, unexplained dyspnea, inappropriate hypotension) or a recent illness, perform a more extensive workup because atrial tachycardia may not be the primary problem; acute pulmonary embolus, acute noncardiac illness, thyroid disease, or drugs (especially sympathomimetics or bronchodilators) can cause atrial tachycardia. In addition, with frequent or incessant tachycardia, tachycardia-induced cardiomyopathy may develop.
Differential Diagnoses
- Atrial Fibrillation
- Atrial Flutter
- Atrioventricular Nodal Reentry Tachycardia (AVNRT)
- Paroxysmal Supraventricular Tachycardia
Shine KI, Kastor JA, Yurchak PM. Multifocal atrial tachycardia. Clinical and electrocardiographic features in 32 patients. N Engl J Med. Aug 15 1968;279(7):344-9. [Medline].
Weber R, Letsas KP, Arentz T, Kalusche D. Adenosine sensitive focal atrial tachycardia originating from the non-coronary aortic cusp. Europace. Jun 2009;11(6):823-6. [Medline].
Ma G, Brady WJ, Pollack M, Chan TC. Electrocardiographic manifestations: digitalis toxicity. J Emerg Med. Feb 2001;20(2):145-52. [Medline].
McCord J, Borzak S. Multifocal atrial tachycardia. Chest. Jan 1998;113(1):203-9. [Medline].
[Guideline] Blomström-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol. Oct 15 2003;42(8):1493-531. [Medline]. [Full Text].
Wu RC, Berger R, Calkins H. Catheter ablation of atrial flutter and macroreentrant atrial tachycardia. Curr Opin Cardiol. Jan 2002;17(1):58-64. [Medline].
Knecht S, Veenhuyzen G, O'Neill MD, Wright M, Nault I, Weerasooriya R, et al. Atrial tachycardias encountered in the context of catheter ablation for atrial fibrillation part ii: mapping and ablation. Pacing Clin Electrophysiol. Apr 2009;32(4):528-38. [Medline].
Kastor JA. Multifocal atrial tachycardia. N Engl J Med. Jun 14 1990;322(24):1713-7. [Medline].
Cohen L, Kitzes R, Shnaider H. Multifocal atrial tachycardia responsive to parenteral magnesium. Magnes Res. Dec 1988;1(3-4):239-42. [Medline].
Iseri LT, Fairshter RD, Hardemann JL, Brodsky MA. Magnesium and potassium therapy in multifocal atrial tachycardia. Am Heart J. Oct 1985;110(4):789-94. [Medline].
McCord JK, Borzak S, Davis T, Gheorghiade M. Usefulness of intravenous magnesium for multifocal atrial tachycardia in patients with chronic obstructive pulmonary disease. Am J Cardiol. Jan 1 1998;81(1):91-3. [Medline].
Ho KM. Intravenous magnesium for cardiac arrhythmias: jack of all trades. Magnes Res. Mar 2008;21(1):65-8. [Medline].
Parillo JE. Treating Multifocal Atrial Tachycardia (MAT) in a critical care unit: new data regarding verapamil and metoprlol. Update Crit Care Med. 1987;2:3-5.
Arsura E, Lefkin AS, Scher DL, Solar M, Tessler S. A randomized, double-blind, placebo-controlled study of verapamil and metoprolol in treatment of multifocal atrial tachycardia. Am J Med. Oct 1988;85(4):519-24. [Medline].
Arsura EL, Solar M, Lefkin AS, Scher DL, Tessler S. Metoprolol in the treatment of multifocal atrial tachycardia. Crit Care Med. Jun 1987;15(6):591-4. [Medline].
Hazard PB, Burnett CR. Treatment of multifocal atrial tachycardia with metoprolol. Crit Care Med. Jan 1987;15(1):20-5. [Medline].
Adcock JT, Heiselman DE, Hulisz DT. Continuous infusion diltiazem hydrochloride for treatment of multifocal atrial tachycardia (abstract). Clin Res. 1994;42:430A.
Aronow WS, Plasencia G, Wong R. Effect of verapamil versus placebo on PAT and MAT. Current Ther Res. 1980;27:823-29.
Hazard PB, Burnett CR. Verapamil in multifocal atrial tachycardia. Hemodynamic and respiratory changes. Chest. Jan 1987;91(1):68-70. [Medline].
Levine JH, Michael JR, Guarnieri T. Treatment of multifocal atrial tachycardia with verapamil. N Engl J Med. Jan 3 1985;312(1):21-5. [Medline].
Salerno DM, Anderson B, Sharkey PJ, Iber C. Intravenous verapamil for treatment of multifocal atrial tachycardia with and without calcium pretreatment. Ann Intern Med. Nov 1987;107(5):623-8. [Medline].
Kouvaras G, Cokkinos DV, Halal G, Chronopoulos G, Ioannou N. The effective treatment of multifocal atrial tachycardia with amiodarone. Jpn Heart J. May 1989;30(3):301-12. [Medline].
Kuralay E, Cingöz F, Kiliç S, Bolcal C, Günay C, Demirkiliç U, et al. Supraventricular tachyarrythmia prophylaxis after coronary artery surgery in chronic obstructive pulmonary disease patients (early amiodarone prophylaxis trial). Eur J Cardiothorac Surg. Feb 2004;25(2):224-30. [Medline].
Hsieh MY, Lee PC, Hwang B, Meng CC. Multifocal atrial tachycardia in 2 children. J Chin Med Assoc. Sep 2006;69(9):439-43. [Medline]. [Full Text].
Pierce WJ, McGroary K. Multifocal atrial tachycardia and Ibutilide. Am J Geriatr Cardiol. Jul-Aug 2001;10(4):193-5. [Medline].
Barranco F, Sanchez M, Rodriguez J, Guerrero M. Efficacy of flecainide in patients with supraventricular arrhythmias and respiratory insufficiency. Intensive Care Med. 1994;20(1):42-4. [Medline].
Tucker KJ, Law J, Rodriques MJ. Treatment of refractory recurrent multifocal atrial tachycardia with atrioventricular junction ablation and permanent pacing. J Invasive Cardiol. Sep 1995;7(7):207-12. [Medline].

